Download Leukaemia Section inv(12)(p13q15) ETV6/PTPRR Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Neuronal ceroid lipofuscinosis wikipedia , lookup

Frameshift mutation wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Gene nomenclature wikipedia , lookup

Expanded genetic code wikipedia , lookup

Genetic code wikipedia , lookup

Protein moonlighting wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Point mutation wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Helitron (biology) wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
INIST-CNRS
OPEN ACCESS JOURNAL
Leukaemia Section
Short Communication
inv(12)(p13q15) ETV6/PTPRR
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: February 2013
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/inv12p13q15ID1631.html
DOI: 10.4267/2042/51049
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2013 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Clinics and pathology
M2-AML case.
Disease
Genes involved and proteins
Myelodysplastic syndrome (MDS), and acute myeloid
leukemias (AML)
ETV6
Location
12p13
Protein
452 amino acids. ETV6 is composed of a HLH domain
responsible for hetero- and homodimerization in Nterm, and an ETS domain responsible for sequence
specific DNA-binding in C-term (binds to the DNA
sequence
5'-CCGGAAGT-3').
Transcriptional
regulator; tumor suppressor. Involved in bone marrow
hematopoiesis.
Clinics
A 75-year-old female patient presented with refractory
anemia (RA) (Welborn et al., 2004). A 24-year-old
female patient presneted with acute myelogenous
leukemia (M2-AML) (Nakamura et al., 2005).
Prognosis
The patient with RA was alive 14 months after
diagnosis without treatment. The patient with M2-AML
underwent bone marrow transplantation and remained
in remission 44 months after diagnosis.
PTPRR
Genetics
Location
12q15
Protein
657 amino acids. PTPRR belong to the protein tyrosine
phosphatase (PTP) family. PTPRR is composed of a
signal peptide, a hydrophobic region, a transmembrane
region, a kinase interacting motif, and a protein
tyrosine phosphatase domain. PTPRR isoforms are
regulators of MAPK phosphorylation levels. Activated
PKA prevents the PTPRR-MAPK binding and MAPK
inhibition by phosphorylation of the KIM domain of
PTPRR. PTPRR-deficient mice exhibit ataxic
symptoms (Hendriks et al., 2009). PTPRR is down
regulated in colorectal cancer (Menigatti et al., 2009).
Note
Another case of inv(12)(p13q15) was that of a 59 year-old female patient with AML M2. However, the 5'
part of ETV6 was translocated to chromosome15 and
the 3' part of ETV6 to 12q15 (Setoyama et al., 1998).
Therefore the genetic rearrangement is different.
Only the case studied by Nakamura et al., 2005
ascertained the breakpoints within ETV6 and PTPRR.
Cytogenetics
Additional anomalies
+8 and additional abnormalities were present in the RA
case; the inv(12) was the sole anomaly in the
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(7)
494
inv(12)(p13q15) ETV6/PTPRR
Huret JL
Result of the chromosomal
anomaly
ETV6. ETV6/PTPRR lacks protein tyrosine
phosphatase activity. Both truncated ETV6 and
ETV6/PTRPP could be important in leukemogenesis.
Hybrid gene
References
Description
The chimeric DNA joined ETV6 exons 1 to 4 and
PTPRR exons 7 to 14.
Alternative splicing leads to generation of 10
ETV6/PTPRR chimeric cDNAs, of which a truncated
ETV6, due to frameshift, and an ETV6/PTPRR inframe isoform with an open reading frame of 1158
nucleotides coding for 385 amino acids, including the
helix-loop-helix domain of ETV6 and most of the
protein tyrosine phosphatase domain of PTPRR.
Setoyama M, Tojo A, Nagamura F, Asano S, Ishimae M,
Eguchi M, Kamada N. A unique translocation of the TEL gene
in a case of acute myelogenous leukemia with inv(12)(p13q15)
Blood. 1998 Aug 15;92(4):1454-5
Welborn J, Jenks H, Taplett J, Walling P. Inversion of
chromosome 12 and lineage promiscuity in hematologic
malignancies. Cancer Genet Cytogenet. 2004 Jan
15;148(2):91-103
Nakamura F, Nakamura Y, Maki K, Sato Y, Mitani K. Cloning
and characterization of the novel chimeric gene TEL/PTPRR in
acute myelogenous leukemia with inv(12)(p13q13). Cancer
Res. 2005 Aug 1;65(15):6612-21
Fusion protein
Hendriks WJ, Dilaver G, Noordman YE, Kremer B, Fransen JA.
PTPRR protein tyrosine phosphatase isoforms and locomotion
of vesicles and mice. Cerebellum. 2009 Jun;8(2):80-8
Description
The ETV6/PTPRR fusion protein is made of 385 amino
acids (aa), including the helix-loop-helix domain of
ETV6 and most of the protein tyrosine phosphatase
domain of PTPRR. 154 aa come from ETV6 and 231
from PTPRR.
Oncogenesis
Both truncated ETV6 and ETV6/PTPRR were shown
to affect nuclear localization of wild-type ETV6. Both
can heterodimerize with wild-type
Atlas Genet Cytogenet Oncol Haematol. 2013; 17(7)
Menigatti M, Cattaneo E, Sabates-Bellver J, Ilinsky VV, Went
P, Buffoli F, Marquez VE, Jiricny J, Marra G. The protein
tyrosine phosphatase receptor type R gene is an early and
frequent target of silencing in human colorectal tumorigenesis.
Mol Cancer. 2009 Dec 16;8:124
This article should be referenced as such:
Huret JL. inv(12)(p13q15) ETV6/PTPRR. Atlas
Cytogenet Oncol Haematol. 2013; 17(7):494-495.
495
Genet
Related documents
Leukaemia Section t(4;12)(p16;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;12)(p16;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(p36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(p36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(q25;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;12)(q25;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(p24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(p24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;15)(p13;q25) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;15)(p13;q25) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q22;p12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(9;12)(q22;p12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section MDS2 (myelodysplastic syndrome 2 translocation associated) Atlas of Genetics and Cytogenetics
Gene Section MDS2 (myelodysplastic syndrome 2 translocation associated) Atlas of Genetics and Cytogenetics
Leukaemia Section t(6;12)(p21;p13) in lymphoid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section t(6;12)(p21;p13) in lymphoid malignancies Atlas of Genetics and Cytogenetics
Gene Section ABL2 (Abelson homolog 2) Atlas of Genetics and Cytogenetics
Gene Section ABL2 (Abelson homolog 2) Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;12)(p13;p1 3) NIPBL/ETV6 Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;12)(p13;p1 3) NIPBL/ETV6 Atlas of Genetics and Cytogenetics
Gene Section TTL (twelve-thirteen translocation leukemia) Atlas of Genetics and Cytogenetics
Gene Section TTL (twelve-thirteen translocation leukemia) Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;13)(p13;q14) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;13)(p13;q14) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section MNX1 (motor neuron and pancreas homeobox 1)
Gene Section MNX1 (motor neuron and pancreas homeobox 1)
Leukaemia Section t(10;12)(q24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(10;12)(q24;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ETV6 (ETS variant gene 6 (TEL oncogene))
Gene Section ETV6 (ETS variant gene 6 (TEL oncogene))
Gene Section MN1 (meningioma 1) Atlas of Genetics and Cytogenetics
Gene Section MN1 (meningioma 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;18)(p13;q12)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;18)(p13;q12) Atlas of Genetics and Cytogenetics
Leukaemia Section 12p abnormalities in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section 12p abnormalities in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;12)(q26;p13) ETV6/MECOM / t(3;12)(q26;p13) ETV6/EVI1 Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;12)(q26;p13) ETV6/MECOM / t(3;12)(q26;p13) ETV6/EVI1 Atlas of Genetics and Cytogenetics